Diallylnortoxiferine and tubocurarine were compared clinically in 493 adult patients undergoing a variety of surgical procedures. Diallylnortoxiferine was found to be approximately twice as potent as tubocurarine. Equipotent doses produced neuromuscular block of the same degree and duration. The incidence of hypotension, its degree and its age distribution are equal. Hypotension occurred in both groups, and its incidence was higher in patients above 40 years, and in patients with an initial blood pressure above 150 mm Hg. Both relaxants are adequately reversed with a mixture of atropine 0.02 mg/kg and neostigmine 0.05 mg/kg, provided an overdose of the relaxant used is avoided.
The effect of diallylnortoxiferine on neuromuscular transmission has been investigated in the human by Baraka and Geddes (1963, unpublished) using the twitch response to ulnar nerve stimulation. The drug produced antidepolarizing neuromuscular block characterized by tetanic fade and post-tetanic facilitation. Its potency was double that of tubocurarine; equipotent doses produced the same degree and duration of neuromuscular block ( fig. 1) .
A clinical comparison between tubocurarine and diallylnortoxiferine in children was carried out by Bush (1965) . Diallylnortoxiferine was found to be approximately 2.1 times as potent as tubocurarine.
The present investigation was undertaken to .
Mkul.iL-inin
compare clinically both relaxants in adult patients with particular reference to the dose requirements, effect on blood pressure and reversibility with neostigmine.
METHOD
The patients investigated were 493 adults of ages ranging from 15 to 75 years, undergoing a variety of operations. The anaesthetic technique was standardized. Premedication consisted of pethidine 100 mg and atropine 0.6 mg injected intramuscularly 1 hour before operation. Sleep was induced with thiopentone 250 mg. This was followed by suxamethonium 100 mg to facilitate oral endotracheal intubation. Anaesthesia was then maintained by a mixture of nitrous oxide (3 l./min) and oxygen (1 l./min). Patients were hyperventilated throughout the procedure using a Boyle Mark HI sodalime absorber. When the patients showed recovery from suxamethonium block, either tubocurarine or diallylnortoxiferine was injected intravenously in divided doses. Tubocurarine was used in 215 patients, and diallylnortoxiferine was used in a further 278 patients (table I) . Tubocurarine 15 mg or diallylnortoxiferine 10 mg was injected intravenously. Thereafter increments of tubocurarine 5 mg or diallynortoxiferine 2.5 mg were injected with intervals of 2 minutes between them until adequate muscular relaxation and complete control of pulmonary ventilation was achieved.
After the initial dose was completed further incremental doses of tubocurarine 5 mg or diallylnortoxiferine 2.5 mg were then administered as required to maintain adequate relaxation. The cumulative doses required at different rime intervals were calculated.
Systolic blood pressure was measured by palpation before and after the injection of the initial dose of relaxant. Hypotension was only considered if it occurred within the 10-minute period following the injection of relaxant and if the maximal fall exceeded 20 mm Hg. This policy was adopted to exclude most of the extraneous factors which might lower the blood pressure during the procedure.
At the termination of operation, neuromuscular block was reversed in all patients with a mixture of atropine 0.02 mg/kg and neostigmine 0.05 m gAg (Baraka, 1967a) . Adequate ventilation was maintained throughout the period of reversal. Respiration was considered adequate in the presence of good air entry, not associated with a tracheal tug or intercostal retraction. Lead II of the electrocardiogram was monitored continuously on an oscilloscope.
RESULTS

Requirements of tubocurarine and diallylnortoxi-
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The incidence of hypotension, its degree and its age distribution are shown in tables VI, VII and VEIL As seen from the comparison, there was no statistically significant difference between the two relaxants as regards the incidence of hypotension, its degree or age distribution. Considering both groups together the incidence of hypotension was higher in patients above 40 years (table IX) . In both groups, the incidence of hypotension was higher in patients having a pre-relaxant blood pressure above 150 mm Hg (table X) .
Reversal with atropine-neostigmine mixture.
The intravenous injection of ±e mixture (atropine 0.02 mg/kg + neostigmine 0.05 mg/kg) produced adequate and safe reversal in all the cases irrespective of the relaxant used.
DISCUSSION
The present clinical comparison between tubocurarine and diallylnortoxiferine confirms the results of the twitch response to ulnar nerve stimulation. Diallylnortoxiferine is approximately twice as potent as tubocurarine. The ratio between the doses required at different time intervals remained virtually constant up to 3 hours. It is concluded that equipotent doses produce not only the same degree but also the same duration of neuromuscular block.
The dose required to maintain relaxation decreases with time. It seems that elimination of both tubocurarine and diallylnortoxiferine is an exponential process.
Reversal of neuromuscular block with neostigmine is adequate with both relaxants. This has been observed in adult patients by Lund and Stovner (1962) and in children by Bush (1965) . However, Hunter (1964) observed that diallyinortoxiferine was not adequately reversed with neostigmine. This can be attributed to the degree of neuromuscular block at the time of reversal; Hunter used maintenance doses of 5 mg in some patients. Baraka (1967b) observed that the effect of neostigmine is inversely proportional to the degree of tubocurarine block; an overdose (absolute or relative) is inadequately reversed. The same finding would apply to other antidepolarizing relaxants.
Both tubocurarine and diallylnortoxiferine can cause hypotension. The incidence of hypotension, its degree and its age distribution were equal after equipotent doses. In both groups, the incidence is more in elderly patients above 40 years, and in patients with an initial blood pressure above 150 mm Hg. Younger and normotensive patients are less vulnerable, probably due to their active compensatory mechanisms. 
